✦ LIBER ✦

Didanosine, a new antiretroviral drug

✍ Scribed by Franssen, R. M. E. ;Meenhorst, P. L. ;Koks, C. H. W. ;Beijnen, J. H.

Publisher: Springer
Year: 1992
Tongue: Dutch
Weight: 910 KB
Volume: 14
Category: Article
ISSN: 1573-739X
DOI: 10.1007/bf01977617

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New antiretroviral drugs in clinical use

✍ Pimpanada Chearskul; Chokechai Rongkavilit; Hossam Al-Tatari; Basim Asmar 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 847 KB

Centrosome amplification induced by the

Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine

✍ Mia Yu; Yvona Ward; Miriam C. Poirier; Ofelia A. Olivero 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

Depletion of mitochondrial DNA in liver

Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine

✍ Ulrich A. Walker; Jochen Bäuerle; Montse Laguno; Javier Murillas; Stefan Mauss; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

The "D drug" HIV reverse-transcriptase inhibitors zalcitabine, didanosine, and stavudine are relatively strong inhibitors of polymerase-gamma compared with the "non-D drugs" zidovudine, lamivudine, and abacavir. D drugs deplete mitochondrial DNA (mtDNA) in cultured hepatocytes. This mtDNA depletion

Adherence to Antiretroviral Therapy Amon

Adherence to Antiretroviral Therapy Among HIV-Infected Drug Users: A Meta-Analysis

✍ Monica Malta; Monica M. F. Magnanini; Steffanie A. Strathdee; Francisco I. Basto 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 376 KB

Overcoming resistance to existing therap

Overcoming resistance to existing therapies in HIV-infected patients: The role of new antiretroviral drugs

✍ Carlo-Federico Perno; Graeme Moyle; Chris Tsoukas; Winai Ratanasuwan; Jose Gatel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract Resistance to available antiretroviral (ARV) agents is of increasing concern, and development of novel agents that address this problem has been identified as a major public health priority. As ARV resistance becomes more prevalent with extended use of existing agents, individuals with

Trends in drug resistance mutations in a

Trends in drug resistance mutations in antiretroviral-naïve intravenous drug users of Rio de Janeiro

✍ Sylvia Lopes Maia Teixeira; Francisco Inácio Bastos; Mariana A. Hacker; Monick L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract DNA sequencing of a __pol__ gene fragment from drug‐naive injecting drug users samples obtained at two time points of the Brazilian AIDS epidemic (Pre‐HAART era: 1994 to early 1997, n = 27; post‐HAART era: 1999–2001, n = 38) was undertaken to assess HIV‐1 antiretroviral drug resistance